Vetoquinol Financial Statements From 2010 to 2025
| VETO Stock | EUR 73.50 0.80 1.10% |
Check Vetoquinol financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vetoquinol's main balance sheet or income statement drivers, such as , as well as many indicators such as . Vetoquinol financial statements analysis is a perfect complement when working with Vetoquinol Valuation or Volatility modules.
Vetoquinol |
Vetoquinol Company Return On Equity Analysis
Vetoquinol's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Vetoquinol Return On Equity | 0.11 |
Most of Vetoquinol's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vetoquinol is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Vetoquinol has a Return On Equity of 0.11. This is 100.46% lower than that of the Pharmaceuticals sector and 94.88% lower than that of the Health Care industry. The return on equity for all France stocks is 135.48% lower than that of the firm.
Vetoquinol Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Vetoquinol's current stock value. Our valuation model uses many indicators to compare Vetoquinol value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vetoquinol competition to find correlations between indicators driving Vetoquinol's intrinsic value. More Info.Vetoquinol is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.70 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Vetoquinol is roughly 1.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vetoquinol by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vetoquinol's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Vetoquinol Financial Statements
Vetoquinol stakeholders use historical fundamental indicators, such as Vetoquinol's revenue or net income, to determine how well the company is positioned to perform in the future. Although Vetoquinol investors may analyze each financial statement separately, they are all interrelated. For example, changes in Vetoquinol's assets and liabilities are reflected in the revenues and expenses on Vetoquinol's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Vetoquinol. Please read more on our technical analysis and fundamental analysis pages.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. Vetoquinol SA was founded in 1933 and is headquartered in Lure, France. Vetoquinol operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 2004 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Vetoquinol Stock
Vetoquinol financial ratios help investors to determine whether Vetoquinol Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vetoquinol with respect to the benefits of owning Vetoquinol security.